MedPath
NMPA Approval

Acalabrutinib Capsules

国药准字HJ20233138

August 29, 2023

Drug Information

阿可替尼胶囊

康可期

胶囊剂

100mg

化学药品

August 29, 2023

March 20, 2028

Company Information

Applicant Company

66 Talavera Road Macquarie Park NSW 2113 AUSTRALIA

Manufacturing Company

ASTRAZENECA AB

Gartunavagen Sodertalje S-15257 Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿可替尼胶囊 - NMPA 批准文号 | MedPath